PTK2 KO cell lysate available now. KO validated by Western blot. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 16 bp deletion in exon 4 and 17 bp deletion in exon 4.
FADK, FADK 1, FAK related non kinase polypeptide, FAK1_HUMAN, FRNK, Focal adhesion Kinase, Focal adhesion kinase 1, Focal adhesion kinase isoform FAK Del33, Focal adhesion kinase related nonkinase, PPP1R71, PTK2 protein tyrosine kinase 2, Protein phosphatase 1 regulatory subunit 71, Protein-tyrosine kinase 2, Ptk2, p125FAK, pp125FAK
PTK2 KO cell lysate available now. KO validated by Western blot. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 16 bp deletion in exon 4 and 17 bp deletion in exon 4.
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.
Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.
User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.
This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.
Focal Adhesion Kinase (FAK) also known as Protein Tyrosine Kinase 2 (PTK2) is a non-receptor tyrosine kinase. This protein has a molecular weight of approximately 125 kDa. FAK is expressed at high levels in brain muscle and liver tissues. Mechanically FAK plays a role in cellular adhesion and migration by regulating integrin signaling and cell-extracellular matrix interactions. FAK auto-phosphorylates at tyrosine residue 397 creating a binding site for Src family kinases and promoting downstream signaling pathways.
Focal Adhesion Kinase participates in the formation of focal adhesions which are complexes that connect the cytoskeleton to the extracellular matrix. The FAK protein functions as an important signaling node in these structures allowing for the assembly of multiprotein signal transduction complexes. FAK also controls cellular processes such as spreading motility and survival. The interaction with proteins such as Src kinases paxillin and talin facilitates its biological roles in cell signaling.
Focal Adhesion Kinase engages in the regulation of the MAPK/ERK signaling pathway and the PI3K/AKT pathway. These pathways are instrumental for cell proliferation survival and migration. In these pathways FAK interacts with proteins such as PI3K Grb2 and Sos linking integrin-mediated signals with downstream effects that influence cell behavior and survival.
Altered FAK signaling has ties to cancer progression and metastasis as well as cardiovascular diseases. In cancer the overexpression of FAK and its interaction with proteins like Src and VEGFR can drive tumor growth and angiogenesis. In cardiovascular diseases improper FAK activation can lead to aberrant heart tissue remodeling and associated pathologies. Abnormalities in FAK signaling pathways can therefore contribute significantly to the development and progression of these diseases.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
Lane 2: A431 cell lysate (20 μg)
Lane 3: Wild-type HEK-293T cell lysate (20 μg)
Lane 4: PTK2 knockout HEK-293T cell lysate (20 μg)
Lanes 1 - 4: Merged signal (red and green). Green - Anti-FAK antibody [EP695Y] ab40794 observed at 119 kDa. Red - loading control, Anti-GAPDH antibody [6C5] - Loading Control ab8245 observed at 37 kDa.
Anti-FAK antibody [EP695Y] ab40794 was shown to react with FAK in wild-type HEK-293T cells. Loss of signal was observed when knockout cell line Human PTK2 (FAK) knockout HEK-293T cell line ab255421 (knockout cell lysate ab263766) was used. Wild-type and FAK knockout samples were subjected to SDS-PAGE. Anti-FAK antibody [EP695Y] ab40794 and Anti-GAPDH antibody [6C5] - Loading Control (Anti-GAPDH antibody [6C5] - Loading Control ab8245) were incubated overnight at 4°C at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes: Western blot - Anti-FAK antibody [EP695Y] (Anti-FAK antibody [EP695Y] ab40794) at 1/1000 dilution
Lane 1: HeLa cell lysate at 20 µg
Lane 2: A431 cell lysate at 20 µg
Lane 2: Western blot - Human PTK2 (FAK) knockout HEK-293T cell line (Human PTK2 (FAK) knockout HEK-293T cell line ab255421)
Lane 3: Wild-type HEK-293T cell lysate at 20 µg
Lane 4: PTK2 knockout HEK-293T cell lysate at 20 µg
All lanes: Western blot - Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed ab216773) at 1/20000 dilution
Performed under reducing conditions.
Predicted band size: 119 kDa
Observed band size: 119 kDa, 37 kDa
Lane 2: A431 cell lysate (20 μg)
Lane 3: Wild-type HEK-293T cell lysate (20 μg)
Lane 4: PTK2 knockout HEK-293T cell lysate (20 μg)
Lanes 1 - 4: Merged signal (red and green). Green - Anti-FAK antibody [EP1831Y] ab76496 observed at 119 kDa. Red - loading control, Anti-GAPDH antibody [6C5] - Loading Control ab8245 observed at 37 kDa.
Anti-FAK antibody [EP1831Y] ab76496 was shown to react with FAK in wild-type HEK-293T cells. Loss of signal was observed when knockout cell line Human PTK2 (FAK) knockout HEK-293T cell line ab255421 (knockout cell lysate ab263766) was used. Wild-type and FAK knockout samples were subjected to SDS-PAGE. Anti-FAK antibody [EP1831Y] ab76496 and Anti-GAPDH antibody [6C5] - Loading Control (Anti-GAPDH antibody [6C5] - Loading Control ab8245) were incubated overnight at 4°C at 1 in 500 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes: Western blot - Anti-FAK antibody [EP1831Y] (Anti-FAK antibody [EP1831Y] ab76496) at 1/500 dilution
Lane 1: HeLa cell lysate at 20 µg
Lane 2: A431 cell lysate at 20 µg
Lane 2: Western blot - Human PTK2 (FAK) knockout HEK-293T cell line (Human PTK2 (FAK) knockout HEK-293T cell line ab255421)
Lane 3: Wild-type HEK-293T cell lysate at 20 µg
Lane 4: PTK2 knockout HEK-293T cell lysate at 20 µg
All lanes: Western blot - Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed ab216773) at 1/20000 dilution
Performed under reducing conditions.
Predicted band size: 119 kDa
Observed band size: 119 kDa, 37 kDa
Allele-1: 17 bp deletion in exon 4; Allele-2: 16 bp deletion in exon 4
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com